Biotricity (BTCY) Stock Chart & Stock Price History $0.60 -0.03 (-4.82%) As of 03:58 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainSEC FilingsTrendsBuy This Stock Biotricity Stock Price Performance The Biotricity (BTCY) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 49.44%, with a year-to-date return of 106.97%. In the past month, the stock has increased 37.87%, reflecting recent market activity. As of the latest close, Biotricity traded at $0.63 with a market cap of $15.71 million and volume of 49,487 shares. Receive BTCY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Biotricity and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+11.11%1 Month Performance+37.87%3 Month Performance+24.53%Year-To-Date Performance+106.97%1 Year Performance+49.44% BTCY Stock Chart for Monday, August, 18, 2025 BTCY Chart by TradingView Biotricity Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/15/2025$0.54$0.63+16.74%$0.64$0.6049,487 shs$15.71 million08/14/2025$0.54$0.54$0.61$0.54198,898 shs$13.45 million08/13/2025$0.50$0.54+8.00%$0.58$0.4679,257 shs$13.45 million08/12/2025$0.49$0.50+1.83%$0.51$0.4422,883 shs$12.46 million08/11/2025$0.44$0.49+11.29%$0.49$0.4431,707 shs$12.23 million08/08/2025$0.47$0.44-6.15%$0.50$0.4444,734 shs$10.99 million08/07/2025$0.49$0.47-3.87%$0.48$0.434,887 shs$11.71 million08/06/2025$0.44$0.49+11.14%$0.49$0.4239,741 shs$12.18 million08/05/2025$0.36$0.44+22.22%$0.45$0.3889,988 shs$10.96 million08/04/2025$0.39$0.36-6.49%$0.40$0.3643,986 shs$8.97 million Get the Latest News and Ratings for BTCY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Biotricity and its competitors with MarketBeat's FREE daily newsletter. 08/01/2025$0.39$0.39-0.77%$0.40$0.3659,775 shs$9.59 million07/31/2025$0.45$0.39-13.59%$0.44$0.3821,042 shs$9.67 million07/30/2025$0.38$0.45+19.73%$0.45$0.4036,374 shs$11.19 million07/29/2025$0.40$0.38-6.25%$0.41$0.3836,036 shs$9.34 million07/28/2025$0.48$0.40-17.36%$0.46$0.4075,222 shs$9.97 million07/25/2025$0.50$0.48-3.16%$0.50$0.484,969 shs$12.06 million07/24/2025$0.50$0.50+0.16%$0.50$0.481,196 shs$12.45 million07/23/2025$0.51$0.50-2.16%$0.50$0.4849,385 shs$12.43 million07/22/2025$0.48$0.51+6.25%$0.52$0.4969,830 shs$12.71 million07/21/2025$0.44$0.48+10.29%$0.51$0.4586,539 shs$11.96 million07/18/2025$0.39$0.44+12.57%$0.45$0.38110,119 shs$10.84 million07/17/2025$0.38$0.39+2.14%$0.46$0.3542,903 shs$9.63 million Related Companies Milestone Scientific Stock Price Chart Daxor Stock Price Chart Fractyl Health Stock Price Chart Nephros Stock Price Chart EDAP TMS Stock Price Chart IceCure Medical Stock Price Chart WORK Medical Technology Group Stock Price Chart Zynex Stock Price Chart Plus Therapeutics Stock Price Chart Titan Medical Stock Price Chart Receive BTCY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Biotricity and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:BTCY) was last updated on 8/18/2025 by MarketBeat.com Staff From Our PartnersWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biotricity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biotricity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access